Syöpätautien klinikka

Julkaisut 2011
Publications 2011

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Avoranta ST et al. Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo) radiotherapy.
2 Buhmeida A et al. Prognostic value of mitotic counts in breast cancer of Saudi Arabian patients.
3 Buhmeida A et al. RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency.
4 Costa S et al. Neoplasia invasiva della vagina.
5 Costa S et al. Infezioni virali: Human papillomavirus (HPV).
6 Costa S et al. Neoplasia intraepiteliale della vagina (VaIN): epidemiologia, eziopatogenesi e diagnosi.
7 Early Breast Cancer Trialists' Collaborative Group (EBCTCG) et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
8 Early Breast Cancer Trialists' Collaborative Group et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis if individual patient data for 10,801 women in 17 randomised trials.
9 El Gehani K et al. Angiogenesis in urinary bladder carcinoma as defined by microvessel density (MVD) after immunohistochemical staining for Factor VIII and CD31.
10 Heigener D. F et al. Second-line erlotinib in patients with advanced non-small-cell lung cancer: Subgroup analyses from the TRUST study.
11 Hilli J et al. NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer.
12 Högel H et al. Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.
13 Izewska J, Salminen E. Role of quality audits: view from the IAEA.
14 Joensuu H et al. Very high quantitative tumor HER2 content and outcome in early breast cancer.
15 Joensuu K et al. Interaction between marrow-derived human mesenchymal stem cells and peripheral blood mononuclear cells in endothelial cell differentiation.
16 Kauhanen S et al. Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
17 Kellokumpu-Lehtinen P-L et al. Anaemia: a rare but neglected problem among Finnish patients receiving chemotherapy for solid tumours.
18 Kero K et al. Human papillomavirus genotypes in male genitalia and their concordance among pregnant spouses participating in the Finnish family HPV study.
19 Klepstad P et al. Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients.
20 Korkeila E. Hypoxia-Associated Biomarkers in Rectal Cancer Treated by Preoperative Radiotherapy or Chemoradiotherapy.
21 Korkeila E et al. Pronounced tumour regression after radiotherapy is associated with negative/weak glucose transporter-1 expression in rectal cancer.
22 Korkeila EA et al. Carbonic anhydrase IX, hypoxia-inducible factor-1 alfa, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer.
23 Korkeila EA et al. Preoperative radiotherapy modulates ezrin expression and its value as a predictive marker in patients with rectal cancer.
24 Koskivuo I et al. Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma.
25 Lindholm P et al. PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremities.
26 Longatto-Filho A et al. Hormonal contraceptives and the length of their use are not independent risk factors for high-risk HPV infections or high-grade CIN.
27 Louvanto K et al. Incident cervical infections with high- and low-risk human papillomavirus (HPV) infections among mothers in the prospective Finnish Family HPV study.
28 Louvanto K et al. Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study.
29 Luutonen S et al. Breast cancer patients receiving postoperative radiotherapy: Distress, depressive symptoms and unmet needs of psychosocial support.
30 Minn H. Aivokasvaimet. PET:n hyöty nyt ja tulevaisuudessa.
31 Minn H, Markkola A. Pään ja kaulan alueen syöpien diagnostiikka kuvantamistutkimusten muuttuvassa maailmassa.
32 Minn H, Vihinen P. Melanoma imaging with highly specific PET probes: ready for prime time?
33 Monsonego J et al. Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.
34 Paaso AE et al. Lack of type-specific concordance between human papillomavirus (HPV) serology and HPV DNA detection in the uterine cervix and oral mucosa.
35 Rappu P et al. Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay.
36 Saarilahti K, Lindholm P. Pään ja kaulan alueen syöpien onkologiset hoidot.
37 Salminen E. Sähköherkkä henkilö lääkärin vastaanotolla - hyvä tutkimus- ja hoitokäytäntö.
38 Salminen E et al. Frequent CT-imaging and testicular cancer - gain or vain? .
39 Salminen EK et al. International Conference on Advances in Radiation Oncology (ICARO):Outcomes of an IAEA meeting.
40 Schrey A et al. Blood pressure and free flap oxygenation in head and neck cancer patients.
41 Seppälä JKH, Kulmala JAJ. Increased beam attenuation and surface dose by different couch inserts of treatment tables used in megavoltage radiotherapy.
42 Seppänen M et al. Positroniemissiotomografian ja tietokonetomografian yhdistelmä syövän diagnostiikassa.
43 Syrjänen K. Dynamics of genital human papillomavirus (HPV) infections among males eventually being uncovered.
44 Syrjänen K. Persistent high-risk human papillomavirus (HPV) infections as surrogate endpoints of progressive cervical disease. Potential new endpoint for efficacy studies with new-generation (non-HPV 16/18) prophylactic vaccines.
45 Syrjänen K et al. Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3.
46 Syrjänen K et al. Risk estimates for persistent high-risk human papillomavirus infections as surrogate endpoints of progressive cervical disease critically depend on reference caegory:. analysis of the combined prospective cohort of the New Independent States of the Former Soviet Union and Latin Americn Screening Studies.
47 Veikkolainen V et al. Function of ERBB4 is determined by alternative splicing.
48 Vihinen P et al. Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report.
49 Vihinen PP et al. Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab.
50 Ålgars A et al. Different role of CD73 in leukocyte trafficking via blood and lymph vessels.
51 Ålgars A et al. EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer.

Julkaisutietokanta 23.11.2012 Publications Data Base 23.11.2012